Guardant Health (GH) Net Equity Issued and Repurchased (2018 - 2023)

Guardant Health has disclosed Net Equity Issued and Repurchased across 2 years of filings, most recently posting $90.6 million for Q4 2023.

• In Q4 2023, Net Equity Issued and Repurchased changed N/A year-over-year to $90.6 million; the TTM figure through Dec 2024 stood at $90.6 million (changed 0.0% YoY), while the FY2025 annual figure was $257.1 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased came in at $90.6 million for Q4 2023 at Guardant Health, down from $254.0 million in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $90.6 million in Q4 2023 to a low of $90.6 million in Q4 2023.